⌘K
Poojaa Precision Engg. Limited is an SME IPO in the precision engineering sector, specializing in gravity, low-pressure, and high-pressure die casting. The company has demonstrated strong financial growth and attractive valuation, but faces significant governance and operational risks, coupled with very low institutional investor interest.
Deterministic verdict 'Avoid': listing=73/Avoid, short=63/Avoid, long=64/Avoid; overall=63.0; confidence=100.0/100 | computed financials: fin=86, growth=100, D/E=0.31 (70% math / 30% model) | market signals: alignment=n/a (OFS None%), anchor quality=70 (marquee 31.0%), GMP trend=rising, overhang=80 (-4.0 pts short-term) | demand profile: reservation weights QIB/NII/Ret 29%/21%/50%, QIB effective demand=0.05x, institutional contribution=1%, breadth=0.53 | unlocks: anchor unlock ~14.1% of issue at T+30d, ~14.1% at T+90d | rule: weak long-term case without compensating demand; severe governance weakness (governance_score 1 <= 2; Avoid ceiling). | Analyst notes: The overall score of 68.5 places Poojaa Precision Engg. in the 'Strong Apply' category. This is primarily driven by the company's exceptional financial performance, including high revenue and PAT growth, healthy margins, strong return ratios, and low debt. The valuation is also attractive compared to its peers. However, the verdict is tempered by significant qualitative concerns: extremely low QIB subscription, governance issues related to past director disqualification and the use of a non-statutory auditor for restated financials, and various operational risks. While the quantitative strengths are compelling, investors should be aware of these underlying risks.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB Shares Offered | 25,00,000 | 47.08% | |
| NII (HNI) Shares Offered | 7,51,200 | 14.15% | |
| Retail Shares Offered | 17,51,200 | 32.98% | |
| Employee Shares Offered | 41,600 | 0.78% | |
| Market Maker Shares Offered | 2,66,000 | 5.01% |
| Investor | |||
|---|---|---|---|
| MOTILAL OSWAL FINVEST LTD. | 1,82,800 | ₹5.5 Cr | 12.19% |
| LRSD SECURITIES PVT.LTD. | 33,600 | ₹1.01 Cr | 2.24% |
| MINT FOCUSED GROWTH FUND PCC-CELL 1 | 1,66,400 | ₹5.01 Cr | 11.1% |
| FINAVENUE CAPITAL TRUST-FINAVENUE GROWTH FUND | 33,600 | ₹1.01 Cr | 2.24% |
| HEM GROWTH OPPORTUNITIES FUND | 1,33,600 | ₹4.02 Cr | 8.91% |
| UPSURGE OPPORTUNITIES FUND I | 66,800 | ₹2.01 Cr | 4.45% |
| ASHIKA GLOBAL FINANCE PVT.LTD. | 33,600 | ₹1.01 Cr | 2.24% |
| SHINCHO ASIA CAPITAL (INCORPORATED VCC SUB FUND) | 33,600 | ₹1.01 Cr | 2.24% |
| SAINT CAPITAL FUND | 33,600 | ₹1.01 Cr | 2.24% |
| INDIA MAX INVESTMENT FUND LTD. | 1,00,000 | ₹3.01 Cr | 6.67% |
| RELIGO COMMODITIES VENTURES TRUST-RELIGO COMMODITIES VENTURE FUND | 50,000 | ₹1.51 Cr | 3.33% |
| ABAKKUS VENTURE OPPORTUNITIES FUND | 4,65,200 | ₹14 Cr | 31.02% |
| MERU INVESTMENT FUND PCC-CELL 1 | 1,33,200 | ₹4.01 Cr | 8.88% |
| TIGER STRATEGIES FUND 1 | 33,600 | ₹1.01 Cr | 2.24% |
Premium gain of 99.67% over issue price.
Exceptional revenue growth (30.03% CAGR) and PAT growth (38.53% CAGR) over the last three years.
Strong profitability with healthy EBITDA (17.62%) and PAT (10.52%) margins.
Excellent return ratios: ROE of 28.18%, ROCE of 26.38%, and RoNW of 23.21%.
Low debt-to-equity ratio of 0.31, indicating a healthy balance sheet.
Attractive valuation with a post-IPO P/E of 19.43x, significantly lower than listed peers.
Specialized technical capabilities in gravity, low-pressure, and high-pressure die casting.
High GMP (99.67% premium) and strong retail/HNI subscription indicating robust demand from non-institutional investors.
Successful execution of expansion plans, diversification into new sectors, increased demand from the automotive industry, and improved operational efficiencies.
Steady growth in line with industry trends, maintenance of current competitive advantages, and effective management of existing risks.
Intensified competition, significant pricing pressure from customers, delays in expansion projects, adverse regulatory changes, or inability to manage working capital effectively.
The high GMP (99.67% premium) and strong retail/HNI subscription indicate a high likelihood of significant listing gains, despite the low QIB interest.
While financials are strong, the extremely low QIB subscription and governance concerns could lead to post-listing volatility and limit short-term upside for institutional investors.
The company's strong growth and attractive valuation are compelling, but significant governance red flags (disqualified directors, auditor issue) and operational risks introduce considerable uncertainty for long-term holding.
Final verdict: Avoid (confidence High).
Positive: Revenue CAGR of 30.03% (FY24-FY26).
Concern: QIB subscription of only 0.17x, indicating very low institutional interest.
Listing-gain vs long-term: Avoid / Avoid.
Concern: Restated financial statements provided by a non-statutory auditor.